Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03BPZ
|
|||
| Drug Name |
Terpyridineplatinum(II) complexe 3
|
|||
| Synonyms |
PMID27977313-Compound-3
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ISIS INNOVATION LIMITED LOWE, Gordon
|
|||
| Structure |
 |
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cytoplasmic thioredoxin reductase (TXNRD1) | Target Info | Inhibitor | [1] |
| Glutathione reductase (GR) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Cytoplasmic thioredoxin reductase (TXNRD1) | Target's Patent Info | [1] | |
| Glutathione reductase (GR) | Target's Patent Info | [1] | ||
| BioCyc | Glutathione redox reactions II | |||
| Glutathione redox reactions I | ||||
| KEGG Pathway | Glutathione metabolism | |||
| Thyroid hormone synthesis | ||||
| Pathwhiz Pathway | Glutamate Metabolism | |||
| Glutathione Metabolism | ||||
| WikiPathways | Metapathway biotransformation | |||
| Sulfation Biotransformation Reaction | ||||
| Oxidative Stress | ||||
| NRF2 pathway | ||||
| Nuclear Receptors Meta-Pathway | ||||
| Selenium Micronutrient Network | ||||
| Glutathione metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Thioredoxin reductase inhibitors: a patent review.Expert Opin Ther Pat. 2017 May;27(5):547-556. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.